Lydiane Mordier

7PUBLICATIONS
58CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 07, 2026
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.

Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa

|Sep 01, 2025
Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.

Lydia Montes, Sylvain Choquet, Madalina Uzunov

|Sep 14, 2024
Teclistamab for relapsed refractory multiple myeloma patients on dialysis.

P Lebreton, F Lachenal, S Bouillie

|May 29, 2024
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03.

Aurore Perrot, Murielle Roussel, Valerie Lauwers-Cances

|Feb 26, 2024
Impressive extramedullary plasmacytoma response in refractory multiple myeloma treated with teclistamab.

Intissar Ben Salah, Lydiane Mordier, Charlotte Leleux

|Jul 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.

Eileen M Boyle, Patrick Blaney, James H Stoeckle

Pageof 2

Frequent Collaborators

2 joint publications

Aurore Perrot

2 joint publications

Damien Roos-Weil

2 joint publications

Jill Corre

1 joint publications

Eileen M Boyle